Co
Non verificato

Contineum Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network
15/05/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
1,00
14/05/2025
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
1,00
28/04/2025
Mercato del lavoro
Finanza
Mercato azionario
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
Biotecnologia
Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development
1,00
17/03/2025
Mercato del lavoro
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors
1,00
12/03/2025
Eventi
Web e Social Network
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
1,00
06/03/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
1,00
04/03/2025
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791
1,00
03/03/2025
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
1,00

Recapiti

Social Media

Seguaci
0
Compatibilità
0